Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Baudax Bio Inc BXRXQ

Baudax Bio, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products for hospital and related acute care settings. The Company's lead product candidate is ANJESO injection. ANJESO is a cyclooxygenase-2 (COX-2), a preferential, non-steroidal anti-inflammatory for the management of moderate to severe pain, which could be administered alone or in combination with other non-NSAID analgesics. Its pipeline of other pharmaceutical products includes two neuromuscular blocking agents (NMBs) and a chemical reversal agent, which are used as muscle paralyzing agents to facilitate intubation and surgery. Its product pipeline includes NMBAs, which are used as muscle paralyzing agents to facilitate intubation and surgery. It is developing intermediate-acting NMBA, BX-1000, an ultrashort-acting NMBA, BX-2000, and a reversal agent specific to its NMBAs. It is also focused on the discovery and development of Treg-based cell therapies for autoimmune diseases.


GREY:BXRXQ - Post by User

Post by WidowAndOrphanon Apr 27, 2020 9:03pm
353 Views
Post# 30960180

You are not alone

You are not aloneHey Subchimes.  I don't spend that much time on here anymore, but I wanted you to know that you are not alone in this one.  Great find.  

Fundamentals are strong.  Chart has looked great and exceeded expectations.  I am also long.  I have been accumulating pre and post offering and love this one.  I suspect this bullboard wont feel as naked in the near future.  Good luck to you and others reading this.  The other stocksites are showing big gains in the number of people watching/following this stock, and I suspect it is only a matter of time until others on this site do as well.  
<< Previous
Bullboard Posts
Next >>